TY  - GEN
AU  - Le Clech,Alice
AU  - Simon-Tillaux,Noémie
AU  - Provôt,François
AU  - Delmas,Yahsou
AU  - Vieira-Martins,Paula
AU  - Limou,Sophie
AU  - Halimi,Jean-Michel
AU  - Le Quintrec,Moglie
AU  - Lebourg,Ludivine
AU  - Grangé,Steven
AU  - Karras,Alexandre
AU  - Ribes,David
AU  - Jourde-Chiche,Noémie
AU  - Rondeau,Eric
AU  - Frémeaux-Bacchi,Véronique
AU  - Fakhouri,Fadi
TI  - Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors
SN  - 1523-1755
PY  - 2020///0921
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - therapeutic use
KW  - Atypical Hemolytic Uremic Syndrome
KW  - genetics
KW  - Child
KW  - Child, Preschool
KW  - Complement Activation
KW  - Complement Inactivating Agents
KW  - Complement System Proteins
KW  - Disease Progression
KW  - Female
KW  - France
KW  - epidemiology
KW  - Hemolytic-Uremic Syndrome
KW  - etiology
KW  - Humans
KW  - Kidney
KW  - immunology
KW  - Kidney Failure, Chronic
KW  - Male
KW  - Middle Aged
KW  - Plasmapheresis
KW  - statistics & numerical data
KW  - Registries
KW  - Renal Dialysis
KW  - Renal Insufficiency, Chronic
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.kint.2019.01.023
ER  -